Industry Insights

Jonathan Bowen from Sanofi UK and Ireland explains how indication-based agreements can remove barriers to patient access to combination cancer therapies

Giles Partington, Lindsay Govan, Paddy O’Hara, Emily Foreman and Jennifer Visser-Rogers from Phastar consider how data can be used to improve research innovations in rare diseases

Veeva talks to Pharmafocus about the best ways that biopharma companies can boost their engagement

Prof Shai Shen-Orr at Cytoreason explores the need for patient heterogeneity in drug development, and suggests why this is so central to successful drug development

Fiona Maini from Medidata Solutions, speaks about pharmaceutical regulation and the opportunities and policy challenges posed by digitalisation and a rapidly evolving industry

Michael Earl, director of pharmaceutical services at Owen Mumford, considers the benefits of connectivity and how this can be best utilised by pharma companies

Rizvan Faruk Batha from Specialist Pharmacy tells Pharmafocus about the history and benefits of compounded medication and why it’s not as common in the UK as the rest of Europe, North America and Australia

Nikunj Desai, head of supply chain at ACG, explores how supply chains can be made more secure and the impacts this may have on the pharma industry

The Follicular Lymphoma Foundation tells Pharmafocus about new research being conducted into blood cancer follicular lymphoma and their new research grant programme

Why do such a significant amount of vaccines in the UK come from Flanders and what does this mean in the ongoing COVID-19 pandemic?

Patients who need to regularly inject themselves can often experience needle anxiety and worry that they may not be able to carry out the procedure correctly each time, which can reduce compliance. With Sidekick, Ypsomed intends to adopt a digital approach to combat this problem, through the development of a molecule specifically targeted towards patients with chronic conditions who need to self-inject therapies on a regular basis.

Opinions have been divided as thousand of NHS operations and appointments were cancelled or postponed due to Queen Elizabeth II’s state funeral, on Monday 19 September. Some patients have cancelled their own appointments, where others have complained of the disruption.